文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

培养阴性脓毒性休克与培养阳性脓毒性休克的比较:一项回顾性队列研究

Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort Study.
PubMed 文献 · Crit Care Med · 2018-01-01
一句话结论培养阴性脓毒性休克与培养阳性者ICU和住院生存率相似,延迟恰当抗菌治疗与两组住院死亡率升高相关(培养阴性OR 1.56,培养阳性OR 1.65)。

该回顾性嵌套队列研究纳入三国28家学术与社区医院ICU 1997至2010年间脓毒性休克患者8670例,其中培养阴性2651例(30.6%)、培养阳性6019例(69.4%)。两组ICU生存率(58.3% vs 59.5%,p=0.276)与住院生存率(47.3% vs 47.1%,p=0.976)相似,病情严重程度(APACHE II 25.7±8.3 vs 25.7±8.1,p=0.723)及血乳酸水平(3.0 mmol/L vs 3.2 mmol/L,p=0.366)亦相似。随着低血压发生后恰当抗菌治疗延迟增加,两组住院死亡率均相应升高(培养阴性OR 1.56,95%CI 1.47-1.66;培养阳性OR 1.65,95%CI 1.59-1.71)。作者结论认为培养阴性脓毒性休克在几乎所有方面表现与培养阳性者相似,早期恰当抗菌治疗似乎改善死亡率。

要点

  • 培养阴性脓毒性休克占脓毒性休克30.6%(2651/8670),与培养阳性者ICU生存率(58.3% vs 59.5%)和住院生存率(47.3% vs 47.1%)相似。
  • 两组病情严重程度相似:APACHE II评分25.7±8.3 vs 25.7±8.1(p=0.723),血乳酸3.0 mmol/L vs 3.2 mmol/L(p=0.366)。
  • 低血压发生后延迟给予恰当抗菌治疗与住院死亡率升高相关:培养阴性组OR 1.56(95%CI 1.47-1.66),培养阳性组OR 1.65(95%CI 1.59-1.71)。
  • 作者认为早期识别和根除感染是改善住院生存最明显的有效策略。

适用人群与场景

  • 来自三国(原文未列国名)28家学术与社区医院ICU的脓毒性休克患者,数据收集于1997至2010年。
  • 培养阴性脓毒性休克2651例(30.6%)与培养阳性脓毒性休克6019例(69.4%)。

研究设计与关键结果

  • 研究类型:回顾性嵌套队列研究,样本量8670例,来自三国28家学术与社区医院ICU,1997至2010年。
  • 培养阴性脓毒性休克2651例(30.6%)vs 培养阳性脓毒性休克6019例(69.4%)。
  • ICU生存率:培养阴性58.3% vs 培养阳性59.5%(p=0.276),无显著差异。
  • 住院生存率:培养阴性47.3% vs 培养阳性47.1%(p=0.976),无显著差异。
  • 病情严重程度:APACHE II评分培养阴性25.7±8.3 vs 培养阳性25.7±8.1(p=0.723)。
  • 血乳酸:培养阴性3.0 mmol/L(四分位距1.7-6.1)vs 培养阳性3.2 mmol/L(四分位距1.8-5.9)(p=0.366)。
  • 低血压发生后延迟恰当抗菌治疗与住院死亡率的关系:培养阴性组OR 1.56(95%CI 1.47-1.66,p<0.0001),培养阳性组OR 1.65(95%CI 1.59-1.71,p<0.0001)。

证据类型、等级与局限

  • 证据类型:回顾性嵌套队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为早期识别和根除感染是改善住院生存最明显的有效策略。
  • 研究显示培养阴性脓毒性休克在几乎所有方面表现与培养阳性者相似,早期恰当抗菌治疗似乎改善死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To determine the clinical characteristics and outcomes of culture-negative septic shock in comparison with culture-positive septic shock.

DESIGN: Retrospective nested cohort study.

SETTING: ICUs of 28 academic and community hospitals in three countries between 1997 and 2010.

SUBJECTS: Patients with culture-negative septic shock and culture-positive septic shock derived from a trinational (n = 8,670) database of patients with septic shock.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Patients with culture-negative septic shock (n = 2,651; 30.6%) and culture-positive septic shock (n = 6,019; 69.4%) were identified. Culture-negative septic shock compared with culture-positive septic shock patients experienced similar ICU survival (58.3% vs 59.5%; p = 0.276) and overall hospital survival (47.3% vs 47.1%; p = 0.976). Severity of illness was similar between culture-negative septic shock and culture-positive septic shock groups ([mean and SD Acute Physiology and Chronic Health Evaluation II, 25.7 ± 8.3 vs 25.7 ± 8.1]; p = 0.723) as were serum lactate levels (3.0 [interquartile range, 1.7-6.1] vs 3.2 mmol/L [interquartile range, 1.8-5.9 mmol/L]; p = 0.366). As delays in the administration of appropriate antimicrobial therapy after the onset of hypotension increased, patients in both groups experienced congruent increases in overall hospital mortality: culture-negative septic shock (odds ratio, 1.56; 95% CI [1.47-1.66]; p < 0.0001) and culture-positive septic shock (odds ratio, 1.65; 95% CI [1.59-1.71]; p < 0.0001).

CONCLUSIONS: Patients with culture-negative septic shock behave similarly to those with culture-positive septic shock in nearly all respects; early appropriate antimicrobial therapy appears to improve mortality. Early recognition and eradication of infection is the most obvious effective strategy to improve hospital survival.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kethireddy S, Bilgili B, Sees A, et al. Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort Study. Crit Care Med. 2018. PMID: 29293143. doi:10.1097/CCM.0000000000002924

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。